Immunogen, Inc. (IMGN) Tops Q4 EPS by 1c; Guides FY13 Loss
Tweet Send to a FriendGet Alerts IMGN Hot Sheet
Price: $16.25 -0.25%
Revenue Growth %: +669.2%
Financial Fact:
Total operating expenses: 26.31M
Today's EPS Names:
RAVN, CAMT, HAST, More
Revenue Growth %: +669.2%
Financial Fact:
Total operating expenses: 26.31M
Today's EPS Names:
RAVN, CAMT, HAST, More
Trade IMGN Now!
Immunogen, Inc. (NASDAQ: IMGN) reported Q4 EPS of ($0.29), $0.01 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $2.95 million versus the consensus estimate of $3.26 million.
Sees FY13 loss of $70 million to $74 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sees FY13 loss of $70 million to $74 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- ReneSola Ltd. (SOL) Posts Q1 Loss of 45c/ADS; Guides Q2, FY13 Shipments
- Stage Stores, Inc. (SSI) Posts Surprise Q1 Loss of 2c/Share
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
